---
category: news
title: "Seismic Therapeutic pledges new era of immunology drug development with machine learning"
excerpt: "Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has announced its launch and $101m in Series A financing. Seismic Therapeutic is accelerating a pipeline of biologics targeting dysregulated ..."
publishedDateTime: 2022-02-14T15:22:00Z
originalUrl: "https://www.biopharma-reporter.com/Article/2022/02/14/Seismic-Therapeutic-immunology-drug-development-with-machine-learning?aca_news_section=Global+Industry+News"
webUrl: "https://www.biopharma-reporter.com/Article/2022/02/14/Seismic-Therapeutic-immunology-drug-development-with-machine-learning?aca_news_section=Global+Industry+News"
type: article
quality: 30
heat: 30
published: false

provider:
  name: biopharma-reporter
  domain: biopharma-reporter.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2022/02/14/seismic-therapeutic-immunology-drug-development-with-machine-learning/13239385-2-eng-GB/Seismic-Therapeutic-immunology-drug-development-with-machine-learning.jpg"
    width: 683
    height: 512
    isCached: true

secured: "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;QpDJ7kgBu9ra9gS3xgGWeA=="
---

